• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs.

作者信息

Morita T, Wada I, Saeki H, Tsuchida S, Weiss R M

出版信息

J Urol. 1987 Jan;137(1):132-5. doi: 10.1016/s0022-5347(17)43904-8.

DOI:10.1016/s0022-5347(17)43904-8
PMID:3795356
Abstract

An experimental model which permits independent changes in ureteral peristalic frequency and bolus volume was employed to explore the effects of autonomic agonists on ureteral bolus volume, peristaltic frequency, intraluminal pressure and flow volume in the dog. Norepinephrine caused an increase in ureteral peristaltic frequency, an elevation in intraureteral baseline and contractile pressure and a decrease in bolus volume, with a resultant decrease in the rate of fluid transport. Isoproterenol caused a decrease in ureteral peristaltic frequency, and a fall in intraureteral baseline and contractile pressure, or it completely abolished peristalsis and bolus formation. These changes were accompanied by an increase in the rate of fluid transport. Acetylcholine caused an increase in ureteral peristaltic frequency, an elevation of intraureteral baseline pressure but no change in contractile pressure, and a small decrease in bolus volume with a resultant small decrease in the rate of fluid transport. These data suggest that the autonomic nervous system may affect urine transport through the ureter by not only regulating peristaltic frequency but also by influencing bolus volume.

摘要

相似文献

1
Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs.
J Urol. 1987 Jan;137(1):132-5. doi: 10.1016/s0022-5347(17)43904-8.
2
Characterization of alpha-adrenoceptor subtypes involved in regulation of ureteral fluid transport.参与输尿管液体转运调节的α-肾上腺素能受体亚型的特征分析。
Tohoku J Exp Med. 1987 Jun;152(2):111-8. doi: 10.1620/tjem.152.111.
3
Effects of noradrenaline, isoproterenol and acetylcholine on ureteral resistance.去甲肾上腺素、异丙肾上腺素和乙酰胆碱对输尿管阻力的影响。
J Urol. 1986 Jun;135(6):1296-8. doi: 10.1016/s0022-5347(17)46078-2.
4
Relationship between pelviureteral peristaltic frequency and urine flow change evoked by autonomic drug administration.
Tohoku J Exp Med. 1985 Jul;146(3):265-71. doi: 10.1620/tjem.146.265.
5
An electroureterographic study of the effects of autonomic drugs on ureteral peristalsis.自主神经药物对输尿管蠕动影响的电输尿管造影研究。
Urol Int. 1974;29(4):280-90. doi: 10.1159/000279926.
6
Effects of autonomic drugs on in vivo recording of electromyograms of canine renal pelvis and ureter.自主神经药物对犬肾盂和输尿管肌电图体内记录的影响。
Urol Int. 1985;40(5):260-6. doi: 10.1159/000281095.
7
The role of ureteral peristaltic rate and bolus volume on increasing urine flow.输尿管蠕动速率和团注量对增加尿流的作用。
Urol Int. 1986;41(3):174-9. doi: 10.1159/000281192.
8
Changes in the ureteral peristaltic rate and the bolus volume in gradual and rapid urinary flow increase.在逐渐和快速的尿流增加过程中输尿管蠕动频率和团块体积的变化。
Tohoku J Exp Med. 1985 Jul;146(3):273-5. doi: 10.1620/tjem.146.273.
9
The pharmacology of the rat ureter in vivo.大鼠输尿管的体内药理学。
Br J Pharmacol. 1972 Apr;44(4):628-33. doi: 10.1111/j.1476-5381.1972.tb07302.x.
10
[Experimental and physiological study on the effects of autonomic drugs upon the pacemaker activity of pelviureteral peristalsis].[自主神经药物对肾盂输尿管蠕动起搏活动影响的实验与生理学研究]
Nihon Heikatsukin Gakkai Zasshi. 1983 Apr;19(2):123-38.

引用本文的文献

1
Activation of Piezo1 or TRPV2 channels inhibits human ureteral contractions via NO release from the mucosa.Piezo1通道或TRPV2通道的激活通过黏膜释放一氧化氮来抑制人类输尿管收缩。
Front Pharmacol. 2024 Jun 26;15:1410565. doi: 10.3389/fphar.2024.1410565. eCollection 2024.
2
Alpha-blockers as medical expulsive therapy for ureteral stones.α受体阻滞剂作为输尿管结石的药物排石疗法
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD008509. doi: 10.1002/14651858.CD008509.pub3.
3
Medical expulsive therapy for ureteric stones: Analysing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials.
输尿管结石的药物排石疗法:基于双盲随机对照试验的系统评价和荟萃分析证据剖析
Arab J Urol. 2017 Apr 18;15(2):83-93. doi: 10.1016/j.aju.2017.03.005. eCollection 2017 Jun.
4
Medical and alternative therapies in urinary tract stone disease.尿路结石疾病的医学及替代疗法。
World J Nephrol. 2015 Nov 6;4(5):492-9. doi: 10.5527/wjn.v4.i5.492.
5
The effect of tamsulosin in the medical treatment of distal ureteral stones.坦索罗辛在远端输尿管结石医学治疗中的作用。
Glob J Health Sci. 2014 Sep 18;6(7 Spec No):44-8. doi: 10.5539/gjhs.v6n7p44.
6
Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.萘哌地尔和/或塞来昔布用于药物治疗远端输尿管结石的疗效比较评估
Urolithiasis. 2014 Dec;42(6):541-7. doi: 10.1007/s00240-014-0708-6. Epub 2014 Aug 20.
7
Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.新型芳基哌嗪衍生物对人前列腺癌细胞系的合成及细胞毒性活性评估
Molecules. 2014 Aug 12;19(8):12048-64. doi: 10.3390/molecules190812048.
8
Kidney stones: an update on current pharmacological management and future directions.肾结石:当前药理学管理及未来方向的更新。
Expert Opin Pharmacother. 2013 Mar;14(4):435-47. doi: 10.1517/14656566.2013.775250.
9
Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.萘哌地尔与托特罗定用于壁内段输尿管结石药物排石治疗的前瞻性随机研究
Urol Res. 2012 Dec;40(6):757-62. doi: 10.1007/s00240-012-0498-7. Epub 2012 Aug 25.
10
Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.比较 α1D-受体拮抗剂萘哌地尔和 α1A/D-受体拮抗剂坦索罗辛在处理输尿管远端结石中的疗效。
World J Urol. 2011 Dec;29(6):767-71. doi: 10.1007/s00345-011-0739-3. Epub 2011 Aug 4.